With pharmaceuticals playing such a big role in healthcare, innovation is a key focus for Novartis. But how are the high R&D costs paid for given that a lot of these disease-curing drugs are too expensive for the poor? We also discuss the controversial pharma clauses in the TPPA as well as the ethics of drug marketing.

<p>With pharmaceuticals playing such a big role in healthcare, innovation is a key focus for Novartis. But how are the high R&amp;D costs paid for given that a lot of these disease-curing drugs are too expensive for the poor? We also discuss the controversial pharma clauses in the TPPA as well as the ethics of drug marketing.</p>

Instagram

Sharper and stronger than a double espresso. The Morning Run stretches your mind and braces you for the business day. It's your fast track into work where you can hit the ground running. From 6am to 10am weekdays, the Morning Run brings you the biggest stories and must-listen-to interviews. Stay enlightened, make educated business and investment decisions.

Advertisement